← Back to Search

Early postpartum visit for Postpartum Depression

N/A
Waitlist Available
Led By Martha B Kole-White, MD
Research Sponsored by Women and Infants Hospital of Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial assesses if an extra early postpartum visit improves attendance at postpartum visits, education, satisfaction, or trust in clinicians.

Eligible Conditions
  • Postpartum Weight Retention
  • Postpartum Depression
  • Patient Satisfaction
  • Trust
  • Breastfeeding

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of postpartum visits attended
Secondary outcome measures
Number of emergency room visits
Number of recommended items covered during postpartum care
Short Assessment of Patient Satisfaction
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Early & Often Postpartum CareExperimental Treatment2 Interventions
Visit at 2-3 and 6 weeks postpartum.
Group II: Standard Postpartum CarePlacebo Group1 Intervention
Visit at 6 weeks postpartum.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Early postpartum visit
2021
N/A
~170
Standard postpartum visit
2021
N/A
~170

Find a Location

Who is running the clinical trial?

Women and Infants Hospital of Rhode IslandLead Sponsor
109 Previous Clinical Trials
38,438 Total Patients Enrolled
3 Trials studying Postpartum Depression
950 Patients Enrolled for Postpartum Depression
Martha B Kole-White, MDPrincipal InvestigatorWomen & Infants Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this a geriatric clinical trial?

"Based on the age parameters set out in the inclusion criteria, the eligible age range for this trial is 13 to 50 years old."

Answered by AI

Does this clinical trial have any restrictions on who can participate?

"The ideal candidate for this clinical trial should be trustworthy and between the ages of adolescence and early adulthood. Around 162 patients are needed for the study."

Answered by AI
~39 spots leftby Apr 2025